Dr. Nathan Rudemiller serves as Director of Bioanalytical Sciences. In his role he provides operational oversight for the bioanalytical lab, which includes the ligand-binding (PK/ADA) and cell-based (Neutralizing antibody/flow cytometry) assay groups. He ensures the lab has all the necessary infrastructure, processes, training, and resources to deliver the highest quality data and service to our sponsors. Nathan is adamant about the importance of the “sponsor experience”. Beyond delivery of timely, high-quality data, Nathan fosters a highly communicative and adaptable environment so Immunologix Laboratories can deliver tailored bioanalytical support for each unique sponsor. Nathan has spent the entirety of his industry career in large molecule bioanalysis, with a particular focus on immunogenicity. He has provided bioanalytical support for a variety of modalities, including MAbs, bi-specifics, fusion molecules, ADCs, ERTs, gene and cell therapies. Nathan obtained his B.S. in Biomedical Sciences from Auburn University, his Ph.D. in Physiology and Translational Sciences from the Medical College of Wisconsin and completed a Post-Doctoral fellowship at Duke University.